Zolgensma Interactions
There are 34 drugs known to interact with Zolgensma (onasemnogene abeparvovec), along with 3 disease interactions. Of the total drug interactions, 7 are major, and 27 are moderate.
- View all 34 medications that may interact with Zolgensma
- View Zolgensma disease interactions (3)
Most frequently checked interactions
View interaction reports for Zolgensma (onasemnogene abeparvovec) and the medicines listed below.
- acetaminophen / caffeine / magnesium salicylate / phenyltoloxamine
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- apremilast
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Autoplex T (anti-inhibitor coagulant complex)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Luxturna (voretigene neparvovec ophthalmic)
- Tracleer (bosentan)
Zolgensma disease interactions
There are 3 disease interactions with Zolgensma (onasemnogene abeparvovec) which include:
Report options
More about Zolgensma (onasemnogene abeparvovec)
- Zolgensma consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Spinraza
Spinraza is used to treat spinal muscular atrophy (SMA) in children and adults. It is administered ...
Evrysdi
Evrysdi is used to treat spinal muscular atrophy (SMA) in adults, children, and infants. It is ...
Nusinersen
Nusinersen is an intrathecal injection used to treat spinal muscular atrophy (SMA) in children and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
